THE KPM GROUP DC LLC

Lobbying for SEBELA PHARMACEUTICALS · Developing therapies for gastrointestinal diseases and women's health

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Georgia · House · Senate · $40,000.00 income · posted Jan 14, 2026

Lobbying activity 1

Health Issues

Requesting CMS change guidance on Bowel Prep Coverage for Screening Colonoscopies Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.